The MacuScope™ is technology that enables you to identify which patients are at risk for Macular Degeneration at the point-of-care. It measures Macular Protective Pigment Density (MPPD) — low MPPD is a major, modifiable risk factor for Macular Degeneration.
Macular Degeneration is the leading cause of vision loss for people over the age of 50 in the Western world. Currently affecting more than 30 million people worldwide, it is expected that this number will triple in the next 20 years. Macular Protective Pigment can protect patients from Macular Degeneration. It is the layer of carotenoids that filters out damaging blue light and neutralizes harmful free radicals. Early detection and monitoring of MPPD, prior to symptoms occurring, is critical to preserving your patient's vision.